Can Vancomycin Cause Confusion?
Yes, vancomycin can cause confusion, though this is not a commonly emphasized adverse effect in the primary FDA labeling or major guidelines. The evidence suggests confusion may occur as part of the clinical presentation in patients receiving vancomycin, particularly in certain contexts.
Evidence from Clinical Practice
The FDA drug label for vancomycin does not explicitly list confusion or altered mental status as a direct adverse effect 1. The primary toxicities emphasized are:
- Nephrotoxicity (acute kidney injury)
- Ototoxicity (hearing loss, tinnitus, vertigo, dizziness)
- Infusion-related reactions (hypotension, red man syndrome)
- Severe dermatologic reactions (DRESS, SJS, TEN)
However, confusion appears as a clinical marker in patients with serious infections treated with vancomycin, suggesting it may be part of the disease process rather than a direct drug effect 2.
Mechanisms and Context
Indirect Causes of Confusion with Vancomycin:
Gut dysbiosis and neurological effects: Research demonstrates that oral vancomycin can cause severe cognitive impairment through gut microbiome disruption. In animal models, oral vancomycin caused gut dysbiosis with increased Proteobacteria, neuroinflammation (NF-κB activation, microglial activation), and significant cognitive dysfunction 3. While this study used oral administration in mice with brain ischemia, it raises concerns about potential CNS effects through the gut-brain axis.
Uremia from nephrotoxicity: Since vancomycin can cause acute kidney injury 1, accumulation of uremic toxins could lead to encephalopathy and confusion, particularly with supratherapeutic levels.
Underlying infection: Patients with serious MRSA infections requiring vancomycin often have sepsis or systemic inflammation that independently causes altered mental status.
Clinical Implications
When to Suspect Vancomycin-Related Confusion:
Check vancomycin levels: Supratherapeutic concentrations (>40 mg/L) are common, especially in patients with eGFR 50-80 mL/min receiving standard dosing 4
Assess renal function: Monitor for nephrotoxicity (≥2-3 consecutive creatinine increases of 0.5 mg/dL or 150% from baseline) 5
Evaluate for other causes: Septic encephalopathy, hypotension, electrolyte disturbances, or concurrent ototoxic/nephrotoxic medications
Consider drug accumulation: Patients with renal impairment are at higher risk for toxicity with prolonged high blood concentrations 1
Monitoring Recommendations
Based on consensus guidelines 5:
- Obtain trough levels before the 4th dose for patients on prolonged therapy
- Target troughs of 15-20 mg/L for serious infections (though newer AUC-guided dosing is preferred 6)
- Monitor renal function in all patients, especially those with baseline impairment or receiving concurrent nephrotoxins
- Adjust dosing based on actual serum concentrations and renal function
Bottom Line
While confusion is not listed as a primary adverse effect of vancomycin, it can occur through indirect mechanisms (nephrotoxicity with uremia, gut dysbiosis affecting the CNS, or as part of the underlying infectious process). If a patient on vancomycin develops confusion, check vancomycin levels, assess renal function, and evaluate for alternative causes before attributing it solely to the drug. The risk may be higher with supratherapeutic levels or in patients with renal impairment.